Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XNV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,231
Award facts
- Contract value 100% obligated
- $24,231.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 for 60 tablets of Jakafi 10 mg on July 18, 2025. The contract, which has no set-aside designation, is set to be completed by July 21, 2025, with performance at the awardee's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities nationwide.
The Defense Logistics Agency, operating under the Department of Defense's Medical Supply Chain, utilizes the SPE2DB program to maintain consistent access to critical pharmaceutical supplies for military healthcare systems. Jakafi (ruxolitinib) is a prescription medication used in the treatment of myeloproliferative neoplasms and other conditions, and this delivery order fulfills immediate medical supply requirements for federal healthcare facilities. DMS Pharmaceutical Group's established role as a federal pharmaceutical supplier, demonstrated through its extensive portfolio of delivery orders covering branded and generic prescription drugs, biologics, and medical consumables, positions the company as a key distribution partner within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6XNV?
SPE2DX25F6XNV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 18, 2025.
How much is contract SPE2DX25F6XNV worth?
The government has obligated $24,231 on SPE2DX25F6XNV.
Is contract SPE2DX25F6XNV an order under another contract?
Yes. SPE2DX25F6XNV is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNV competed?
The extent of competition for SPE2DX25F6XNV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award